Dear colleagues,

Personalized nanomedicine aims at the integration of the rapidly expanding toolbox encompassing “omic” disciplines, biotechnology, nanotechnology, and materials science to develop monitoring and therapeutic strategies fulfilling the specific needs of each individual.
The scope of this Special Issue is to collect the most recent advances in the field of nano-enabled personalized medicine, focusing in particular on two of main the areas of nanomedicine, namely targeted delivery systems and diagnostics. This issue will focus primarily on areas of immunology and associated fields. Specifically, we would encourage nanomedicine and precision medicine manuscripts related to cancer biology, immunology, and neuroscience.
One of the key requirements of personalized medicine is the possibility to monitor analytes with technologies coupling low cost and high sensitivity, allowing for reliable and frequent screening. To this end, we will also consider papers describing novel analytical platforms (especially if featuring multiplexing capability) for the detection of biomarkers and metabolites in test solutions and in real biological fluids that could be integrated into portable, wearable biosensors to be operated at the point-of-care. Devices with multiplexing capability, integrating microfluidics or fabricated by innovative approaches (addittive manufacturing) are most welcome.
As pharmaceutical sciences continue to advance nanotechnology for personalized treatments and diagnostics, there is an increased need for high-quality control and cost-effective process design in manufacturing. Therefore, we encourage submissions which specifically focus on pharmaceutical design and manufacturing in nanomedicine and how the advancement of precision medicine is impacted by these efforts.

Dr. Jelena M. Janjic
Dr. Carlo Augusto Bortolotti
Prof. Dr. Giovanni Tosi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• optical and electronic biosensors
• multiplexing
• portable devices
• point-of-care
• biological fluids
• microfluidics
• nanomedicine design
• nanomedicine manufacturing
• quality control
• colloidal nanosystems
• nanoimaging
• targeted nanotechnology